Tag: KDC-MN-077

  • GHRP-6

    Growth hormone releasing peptide / ghrelin receptor agonist

    A first-generation hexapeptide ghrelin receptor agonist with prominent appetite stimulation, often used as a research-grade alternative to ipamorelin.

    Abstract

    GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2; CAS 87616-84-0; molecular formula C46H56N12O6; molecular weight 873.02) is a first-generation hexapeptide ghrelin receptor agonist. The compound stimulates GH release with kinetics similar to GHRP-2 but produces more pronounced cortisol and prolactin elevation, which has limited its clinical development. GHRP-6 also produces marked appetite stimulation through ghrelin pathway activation, an effect that distinguishes it from later GHRPs and that may be either useful (cachexia, sarcopenia adjunct) or unwanted (weight management contexts) depending on the application. Pharmacokinetics: plasma half-life 15 to 60 minutes; parenteral administration only.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.